Odanacatib
|
|
|
- CAS-Nr.
- 603139-19-1
- Englisch Name:
- Odanacatib
- Synonyma:
- CS-700;MK-0822;Odacatib;ODANACATIB;MK-0822;MK0822;Unii-N673F6W2vh;Odanacatib, >=98%;Odanacatib(Mk0822);(MK0822,Odanacatib);Odanacatib,MK-0822,MK0822
- CBNumber:
- CB52455399
- Summenformel:
- C25H27F4N3O3S
- Molgewicht:
- 525.56
- MOL-Datei:
- 603139-19-1.mol
|
Odanacatib Eigenschaften
- Schmelzpunkt:
- 223-224 °C
- Siedepunkt:
- 681.6±55.0 °C(Predicted)
- Dichte
- 1.35
- storage temp.
- Sealed in dry,Store in freezer, under -20°C
- L?slichkeit
- Chloroform (Slightly, Heated, Sonicated), Methanol (Slightly, Sonicated)
- Aggregatzustand
- Solid
- pka
- 12.06±0.20(Predicted)
- Farbe
- White to Off-White
- Stabilit?t:
- Hygroscopic
- InChIKey
- FWIVDMJALNEADT-SFTDATJTSA-N
- SMILES
- C(NC1(C#N)CC1)(=O)[C@@H](N[C@@H](C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)CC(F)(C)C
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
Achtung
|
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H373 |
Kann die Organe sch?digen bei l?ngerer oder wiederholter Exposition. |
Spezifische Zielorgan-Toxizit?t (wiederholte Exposition) |
Kategorie 2 |
Warnung |
|
P260, P314, P501 |
|
| Sicherheit |
| P260 |
Dampf/Aerosol/Nebel nicht einatmen. |
| P314 |
Bei Unwohlsein ?rztlichen Rat einholen / ?rztliche Hilfe hinzuziehen. |
| P501 |
Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
Odanacatib Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
MK-0822 is a newly developed bone-targeting dual action pro-drug for osteoporosis and bone metastasis. It is also an inhibitor of cathepsin K, an enzyme involved in bone resorption.
Enzyminhibitor
This investigational osteoporosis/bone-metastasis drug (FW = 525.56 g/mol; CAS 603139-19-1), also known by the code name MK-0822 and its systematic name N-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro- 1-[4'-(methylsulfonyl)biphenyl-4-yl]ethyl}-L-leucinamide, targets the cathepsin K, a unique collagenolytic lysosomal cysteine protease that is secreted, thereby facilitating bone resorption by cleaving type-1 collagen under acidic pH. Cathepsin K exhibits a unique cleavage pattern of type I collagen molecules that is fundamentally different from that of other endogenous collagenases. Women receiving ODN (10-50 mg) for 5 years had gains in spine and hip bone mineral density (BMD), showing larger reductions in bone resorption than bone formation markers. Significantly, discontinuation of ODN resulted in reversal of treatment effects. An odanacatib synthesis, which describes a novel stereospecific SN2 triflate displacement of a chiral a-trifluoromethylbenzyl triflate with (S)-g-fluoroleucine ethyl ester, achieves a 61% overall yield in 6 steps.
Odanacatib Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Odanacatib Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 194)Lieferanten
603139-19-1()Verwandte Suche:
- Odanacatib,MK-0822,MK0822
- Pentanamide, N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]ethyl]amino]-, (2S)-
- (2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]ethyl]amino]pentanamide Odanacatib (MK-0822)
- Odanacatib
(2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]ethyl]amino]pentanamide
- (S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-((S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)biphenyl-4-yl)ethylamino)pentanamide
- Odanacatib, >=98%
- MK-0822
- ODANACATIB
- (2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]ethyl]amino]pentanamide
- Unii-N673F6W2vh
- N-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)biphenyl-4-yl]ethyl}-L-leucinamide
- Odanacatib(Mk0822)
- (S)-N-(1-cyanocyclopropyl)-4-fluoro-4-Methyl-2-(((S)-2,2,2-trifluoro-1-(4'-(Methylsulfonyl)-[1,1'-biphenyl]-4-yl)ethyl)aMino)pentanaMide
- (2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-Methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-Methanesulfonylphenyl)phenyl]ethyl]aMino}pentanaMide
- CS-700
- MK-0822;MK0822
- (2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl]ethyl]amino]pentanamide
- (MK0822,Odanacatib)
- Pentanamide,N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S...
- Odanacatib, 10 mM in DMSO
- Odanacatib (MK-0822) ，S1115
- Odacatib
- 603139-19-1
- C25H27F4N3O3S
- API
- Inhibitors
